220. Rapidly progressive glomerulonephritis Clinical trials / Disease details


Clinical trials : 2 Drugs : 5 - (DrugBank : 2) / Drug target gene : 1 - Drug target pathway : 1

  
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02647255
(ClinicalTrials.gov)
March 201621/12/2015Trial of Plasma Exchange for Severe Crescentic IgA NephropathyRandomized Trial of Plasma Exchange as Adjunctive Therapy for Severe Crescentic GlomerUlonephritis of IgA NEphropathy (RESCUE Study)Glomerulonephritis, IGA;Kidney Diseases;Acute Renal Insufficiency;Rapidly Progressive GlomerulonephritisProcedure: Plasma Exchange (PE);Drug: Methylprednisolone pulsePeking University First HospitalNULLTerminated14 Years65 YearsAll10Phase 2/Phase 3China
2NCT00354198
(ClinicalTrials.gov)
August 200618/7/2006Efficacy of Pentoxifylline on Rapidly Progressive GlomerulonephritisClinical Efficacy of Combined Pentoxifylline and Conventional Immunosuppressive Regimens on Patients With Rapidly Progressive GlomerulonephritisGlomerulonephritisDrug: pentoxifylline;Drug: corticosteroidsNational Taiwan University HospitalNational Science Council, TaiwanTerminated20 Years80 YearsBoth7Phase 3Taiwan